These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8439321)

  • 1. Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors.
    Gitay-Goren H; Halaban R; Neufeld G
    Biochem Biophys Res Commun; 1993 Feb; 190(3):702-8. PubMed ID: 8439321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules.
    Gitay-Goren H; Soker S; Vlodavsky I; Neufeld G
    J Biol Chem; 1992 Mar; 267(9):6093-8. PubMed ID: 1556117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells.
    Cohen T; Gitay-Goren H; Sharon R; Shibuya M; Halaban R; Levi BZ; Neufeld G
    J Biol Chem; 1995 May; 270(19):11322-6. PubMed ID: 7744769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific binding of vascular permeability factor to endothelial cells.
    Olander JV; Connolly DT; DeLarco JE
    Biochem Biophys Res Commun; 1991 Feb; 175(1):68-76. PubMed ID: 1998521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin.
    Soker S; Svahn CM; Neufeld G
    J Biol Chem; 1993 Apr; 268(11):7685-91. PubMed ID: 7681826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
    Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
    J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.
    Houck KA; Leung DW; Rowland AM; Winer J; Ferrara N
    J Biol Chem; 1992 Dec; 267(36):26031-7. PubMed ID: 1464614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites.
    Myoken Y; Kayada Y; Okamoto T; Kan M; Sato GH; Sato JD
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5819-23. PubMed ID: 1712106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression of vascular endothelial growth factor and its receptor flt-1 in malignant pleural mesothelioma.
    König J; Tolnay E; Wiethege T; Müller K
    Respiration; 2000; 67(1):36-40. PubMed ID: 10705260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
    Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues.
    Jakeman LB; Winer J; Bennett GL; Altar CA; Ferrara N
    J Clin Invest; 1992 Jan; 89(1):244-53. PubMed ID: 1729274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2.
    Roeckl W; Hecht D; Sztajer H; Waltenberger J; Yayon A; Weich HA
    Exp Cell Res; 1998 May; 241(1):161-70. PubMed ID: 9633524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells.
    Wang DS; Miura M; Demura H; Sato K
    Endocrinology; 1997 Jul; 138(7):2953-62. PubMed ID: 9202240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors.
    Soker S; Goldstaub D; Svahn CM; Vlodavsky I; Levi BZ; Neufeld G
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1339-47. PubMed ID: 7522446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the receptors for vascular endothelial growth factor.
    Vaisman N; Gospodarowicz D; Neufeld G
    J Biol Chem; 1990 Nov; 265(32):19461-6. PubMed ID: 2246236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
    Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
    Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor.
    Graeven U; Rodeck U; Karpinski S; Jost M; Philippou S; Schmiegel W
    Cancer Res; 2001 Oct; 61(19):7282-90. PubMed ID: 11585767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
    Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
    J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulations of vasculatropin/vascular endothelial growth factor bioavailability.
    Plouët J; Bayard F
    Horm Res; 1994; 42(1-2):14-9. PubMed ID: 7959629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.